Skip to main content
. 2020 Jun 2;7(3):269–277. doi: 10.3233/JND-190464

Fig. 4.

Fig. 4

Changes in physical assessments during treatment with eculizumab. Physical parameters were based on a qualitative assessment of selected items from the QMG evaluation and classified as mild, moderate or severe [23]. QMG, Quantitative Myasthenia Gravis.